MedPath

Postoperative Catheterization After Anterior Colporrhaphy

Not Applicable
Conditions
Cystocele
Cystitis
Registration Number
NCT00622076
Lead Sponsor
Atrium Medical Center
Brief Summary

Randomised controled multicenter trial about the appropriate length of postoperative catheterization after anterior colporrhaphy. Patients are included at the moment that they are planned for surgery and are allocated to one of the study arms after the operation in the recovery by a digital randomisation-procedure. 230 patients will be enrolled in the study and half of the patients will have a catheter during five days postoperatively and the other half will be catheterized only during two days. Main outcome measurements regards replacement of a catheter because of bladder retention and the occurence of cystitis.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
230
Inclusion Criteria
  • all patients planned for a cystocele repair
Exclusion Criteria
  • patients who already have voiding problems before the operation not related to the cystocele
  • patients that are not capable of understanding our patient information form because of mental status or language

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
how many patients do need replacement of a catheter because of urine retention in both groups: 2 days versus 5 days in dwelling catheterization after anterior colporrhaphy6-8 hours after removal of catheter
Secondary Outcome Measures
NameTimeMethod
how many patients develop cystitis after catheterization in both groups: 2 days versus 5 days in dwelling catheterization after anterior colporrhaphy6 weeks after surgery

Trial Locations

Locations (2)

atriumMC

🇳🇱

Heerlen, Netherlands

Maastricht university medical center

🇳🇱

Maastricht, Netherlands

atriumMC
🇳🇱Heerlen, Netherlands
Martine Wassen, Drs
Sub Investigator
Paul Kampschöer, Drs
Contact
+31455766666

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.